Publications Database

Farmer C. A. , Thurm A. , Grant P. J. (2013)

Pharmacotherapy for the core symptoms in autistic disorder: Current status of the research.

Drugs

73(4), pp. 303-314.

Read Abstract (New Window)

Feldman H. M. , Kolmen B. K. , Gonzaga A. M. (1999)

Naltrexone and communication skills in young children with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

38(5), pp. 587-593

Read Abstract (New Window)

Gillberg C. (1995)

Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians.

Developmental Medicine and Child Neurology

37(3), pp. 239-245

Read Abstract (New Window)

Gonzalez N. M. et al. (1994)

Naltrexone plasma levels, clinical response and effect on weight in autistic children.

Psychopharmacology Bulletin

30(2), pp. 203-208

Read Abstract (New Window)

Good P. (2006)

Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?

Medical Hypotheses

67(3), pp. 671-672

Gringras P. (2000)

Practical paediatric psychopharmacological prescribing in autism: the potential and the pitfalls.

Autism

4(3), pp. 229-247

Read Abstract (New Window)

Herman B. (1993)

Cardiovascular and other physical effects of acute administration of naltrexone in autistic children.

Journal of Child and Adolescent Psychopharmacology

3(3), pp. 157-168

Herman B. et al. (1989)

Effects of acute administration of naltrexone on cardiovascular function, body temperature, body weight and serum concentrations of liver enzymes in autistic children.

Developmental Pharmacology

12(3), pp. 118-127

Read Abstract (New Window)

King B. H. (2000)

Pharmacological treatment of mood disturbances, aggression and self-injury in persons with pervasive developmental disorders.

Journal of Autism and Developmental Disorders

30(5), pp. 439-445

Read Abstract (New Window)

Knabe R. , Schultz P. , Richard J. (1990)

Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment.

Journal of Autism and Developmental Disorders

20(4), pp. 591-593

Read Extract (New Window)

Kolmen B. K. et al. (1995)

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.

Journal of the American Academy of Child and Adolescent Psychiatry

34(2), pp. 223-231

Read Abstract (New Window)

Kolmen B. K. et al. (1997)

Naltrexone in young autistic children: replication study and learning measures.

Journal of the American Academy of Child and Adolescent Psychiatry

36(11), pp. 1570-1578

Read Abstract (New Window)

Kumar B. et al. (2012)

Drug therapy in autism: a present and future perspective.

Pharmacological Reports

64(6), pp. 1291-1304.

Read Abstract (New Window) Read Full (New Window)

Leboyer M. et al. (1992)

Brief report: a double-blind study of naltrexone in infantile autism.

Journal of Autism and Developmental Disorders

22(2), pp. 309-319

Leboyer M. , Bouvard M. P. , Dugas M. (1998)

Effects of naltrexone on infantile autism.

Lancet

1(8587), p. 715

Lensing P. et al. (1995)

Clinical case report opiate antagonist and event-related desynchronization in 2 autistic boys.

Neuropsychobiology

31(1), pp. 16-23

Read Abstract (New Window)

Lensing P. et al. (1992)

Naltrexone open trial with a 5-year-old-boy. A social rebound reaction.

Acta Paedopsychiatrica

55(3), pp. 169-173

Read Abstract (New Window)

Mahatmya D. , Zobel A. , Valdovinos M. G. (2008)

Treatment approaches for self-injurious behavior in individuals with autism: Behavioral and pharmacological methods.

Journal of Early and Intensive Behavior Intervention

5(1), pp. 106-118.

Read Abstract (New Window) Read Full (New Window)

Masi G. (2004)

Pharmacotherapy of pervasive developmental disorders in children and adolescents.

CNS Drugs

18(14), pp. 1031-1052

Read Abstract (New Window)

Panksepp J. , Lensing P. (1991)

A synopsis of an open-trial of naltrexone treatment of autism with four children.

Journal of Autism and Developmental Disorders

21(2), pp. 243-249

Read Abstract (New Window)